La lettre d'information du Réseau International des Instituts Pasteur
RIIP-Info
 
The Institut Pasteur
International Network Newsletter
 
March 2020
 
COVID-19 - NEWS
The Institut Pasteur International Network mobilized in the surveillance and research on the SARS-CoV-2 virus that appeared in China
 
 
Thanks to the international solidarity shown by the Network, members of the Institut Pasteur International Network are working closely together and exchanging information. The World Health Organization (WHO) lists all confirmed cases of infection with this new coronavirus reported and updates its website regularly. Below you will find a selection of news published by the Institutes of the Network (non-exhaustive list).
 
Institut Pasteur disease webpage
The Institut Pasteur Coronavirus Task Force
Coronavirus: Institut Pasteur warns against false information circulating on social media
HKU-Pasteur Resarch Pole : SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients (The New England Journal of Medicine)
Fiocruz will be helping African countries in the response against the COVID-19
Scientists at Institut Pasteur du Cambodge culture novel coronavirus from patients
CEPI collaborates with the Institut Pasteur in a consortium to develop COVID-19 vaccine
#In the media: How is Africa preparing for the coronavirus epidemic ? Interview with Pierre-Marie Girard, director of the Institut Pasteur International Network
(TV5 Monde)
NEWS
Leishmaniasis: epigenetic mechanisms implicated in infection
 
 
Leishmaniasis is a human and animal disease caused by parasites of the Leishmania genus that affects 12 million people worldwide. It is endemic in around a hundred countries and is currently emerging in Europe as a result of climate change and large-scale population movements. Scientists from the Institut Pasteur in Paris, in collaboration with the Institut Pasteur of Shanghai-Chinese Academy of Sciences, have elucidated a new resistance mechanism of the infectious agents of leishmaniasis against host antimicrobial activities. The discovery paves the way for the development of new therapies to eliminate the harmful influence of the parasite.
 
ERA4TB, an international consortium to accelerate the development of comprehensive treatments against tuberculosis
 
 
With a team of more than thirty public and private organisations, including the Institut Pasteur, the Institut Pasteur de Lille and Sciensano, and a budget over 200 million euros, ERA4TB aims to radically transform the way in which new therapies are developed for the treatment of tuberculosis.
 
TEACHING
MOOC : Emerging and re-emerging viruses 
Submission deadline : April 10th, 2020
 
 
As the epidemic of COVID-19 spreads worldwide, find the MOOC on emerging and re-emerging viruses, which are among the various pathogens responsible for recent epidemic
This MOOC describes well-known emerging and re-emerging viruses in great detail. It discusses with renowned experts the conditions that favour their emergence, re- emergence and risk for causing worldwide viral pandemics. On top, it presents measures that help prevent outbreaks and that allow early detection and response mechanisms at the local level by involving health workers, public health laboratories, and decision makers at the national or international level (e.g. at the World Health Organization (WHO).
 
CALL FOR APPLICATIONS
Calmette & Yersin Doctoral Grant 
Submission deadline : May 11th, 2020
 
 
The Calmette and Yersin program aims to promote mobility within the Institut Pasteur International Network. The annual call for applications for doctoral grants is now open. This call is open to all student wishing realize their thesis within an institute of the Network, outside the mainland France.
 
EVENTS
2020 Drug discovery for neglected diseases international congress 
Dates : December 7th and 8th, 2020
Location : Facultad de Información y Comunicación, Universidad de la República, Montevideo, Uruguay
Submission deadline : October 31th, 2020
 
 
This meeting will provide a forum for the presentation and discussion of state-of-the-art research, development and needs in the field of drug discovery against neglected tropical diseases. The topics to be addressed include: targets for drug discovery, hit discovery, mode of action and resistance, hit-to-lead optimization, natural products and in silico approaches.
The goal is to foster efficient and targeted collaborations in a field of common interest, namely, the quest for new lead compounds to develop novel pharmacotherapies against neglected tropical diseases.
 
INSTITUTIONAL
Christian Léonard is the new director of Sciensano
 
 
The Belgian health institute Sciensano has welcomed a new Managing Director on 1 January 2020: Christian Léonard, previously acting Managing Director ad interim of the KCE (Centre fédéral d’Expertise de Soins de Santé). He thus succeeds Myriam Sneyers, who has been Director of Sciensano ad interim since 2018. Christian Léonard will continue the task undertaken by Myriam Sneyers who participated in the creation of the new Institute in April 2018 and was its director during its first 2 years of life.
 
Assoc. Prof. Penka Petrova: new director of the Stephan Angeloff Institute of Microbiology
 
 
Since the 6th of January 2020 the Stephan Angeloff Institute of Microbiology has a new elected Director – Assoc. Prof. Penka Petrova. As a part of the Institut Pasteur International Network (IPIN), the Stephan Angeloff Institute of Microbiology has increased his visibility at the international, regional and national research arena and in Bulgarian society. The Directors (Prof. Angel Galabov (the Director until 2012) and Prof. Hristo Najdenski (the Director until 2019)) of the Institute have always make efforts to strengthen the position of the Institute in the Network.
 
Ronan Jambou, new scientific director of CERMES
 
 
 
Ronan Jambou is appointed Scientific Director of CERMES (Niger) as of 1 February 2020. He succeeds Jean Testa, the first Scientific Director of CERMES, who held this position for 3 years (November 2016-August 2019).
Ronan Jambou is a doctor and scientist, research director at the Institut Pasteur. He is a specialist in parasitology and public health. After a career in the south as a researcher and head of unit (Cameroon, Madagascar, Senegal and Australia) he joined the Institut Pasteur de Côte d'Ivoire in 2014 as an expert seconded to the management, being particularly involved in the development of bioinformatics in Côte d'Ivoire and teaching at the University FH Boigny.
 
 
To suscribe to the RIIP-info newsletter :
 
 
Institut Pasteur
25-28, rue du Docteur Roux
75724 Paris Cedex 15
Facebook
Twitter
LinkedIn
Youtube
 
 
Cet email a été envoyé à liming@ips.ac.cn.
Vous avez reçu cet email car vous vous êtes inscrit à la lettre d'information
du Réseau International des Instituts Pasteur.
 
 
© 2018 Institut Pasteur